Actively Recruiting
Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
Led by Center for International Blood and Marrow Transplant Research · Updated on 2023-05-03
99999999
Participants Needed
1
Research Sites
2035 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary purpose of the Research Sample Repository is to make blood samples available for research studies related to histocompatibility and hematopoietic cell transplantation (HCT) or other cellular therapy. Representatives of participating centers and investigators or research groups may request access to research samples contained in the Research Sample Repository for the purpose of conducting research including: * investigating molecular explanations for histocompatibility or clinical outcomes through analysis of genomic, epigenetic, or other biomolecular data * evaluating the factors that affect transplant or cellular therapy outcome * studying the distribution of HLA tissue types in different populations * studying the success of transplantation, cellular therapies or supportive care in the management of marrow toxic injuries * performing de-linked (anonymous) research
CONDITIONS
Official Title
Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Donors who have donated or are scheduled to donate hematopoietic cells or cellular therapy products to an allogeneic recipient, including adults and children
- All donors registered on the National Marrow Donor Program Registry are eligible
- Testable material from cord blood units infused at centers under the C. W. Bill Young Transplantation Program
- All U.S. recipients of allogeneic or autologous hematopoietic cell transplants or cellular therapies, including adults and children
- Patients treated for marrow toxic injury at centers participating in the Radiation Injury Treatment Network, including adults and children
- Eligible patients may have received supportive care, growth factor support, hematopoietic stem cell transplant, or other medical treatments for marrow toxic injury
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NMDP Biorepository
New Brighton, Minnesota, United States, 55112
Actively Recruiting
Research Team
A
Ashley Spahn
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here